Dublin, April 09, 2025 (GLOBE NEWSWIRE) — The “Marine Derived Drugs Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F” report has been added to ResearchAndMarkets.com’s offering.
The Marine Derived Drugs Market was valued at USD 12.40 Billion in 2024, and is expected to reach USD 20.96 Billion by 2030, rising at a CAGR of 9.10%
The global marine-derived drugs market is a specialized segment of the pharmaceutical industry that leverages bioactive compounds from marine organisms – including algae, sponges, corals, and marine microorganisms – to develop innovative therapeutics. These compounds offer unique pharmacological properties, enabling the creation of next-generation drugs targeting complex medical conditions.
Furthermore, the market is witnessing a strategic shift toward sustainable marine bioprospecting, with algae-derived compounds emerging as a dominant segment due to their scalability and alignment with global sustainability initiatives.
Rich Biodiversity of Marine Ecosystems
The vast and diverse ecosystems of the world’s oceans serve as an untapped reservoir of bioactive compounds with immense pharmaceutical potential. The rich biodiversity of marine environments is a key driver behind the expansion of the global marine-derived drugs market, fueling novel drug discovery and commercialization.
High Cost of Discovery and Development and
One of the most significant challenges in the marine-derived drugs market is the high cost associated with the discovery and development of new drugs. The process of identifying, isolating, and testing marine compounds is time-consuming and resource intensive. Researchers often require specialized equipment and access to remote marine environments, which adds to the overall expense.
Advancements in Genomic and Metagenomic Technologies
Genomic and metagenomic technologies are revolutionizing marine drug discovery. By analyzing the DNA of marine organisms and their symbiotic microorganisms, researchers can identify potential drug candidates more efficiently. These techniques enable the discovery of previously hidden bioactive compounds and hold the promise of accelerating drug development.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 185 |
| Forecast Period | 2024 – 2030 |
| Estimated Market Value (USD) in 2024 | $12.4 Billion |
| Forecasted Market Value (USD) by 2030 | $20.96 Billion |
| Compound Annual Growth Rate | 9.1% |
| Regions Covered | Global |
Report Scope:
Key Market Players
- Abbott Laboratories Inc
- Bayer AG
- Takeda Pharmaceutical Co Ltd
- Marine Polymer Technologies Inc
- Sanofi SA
- Aphios Corp
- Aker BioMarine ASA
- AbbVie Inc
- GSK PLC
Marine Derived Drugs Market, By Type:
- Ether
- Peptide
- Phenol
- Steroid
Marine Derived Drugs Market, By Source:
- Algae
- Invertebrates
- Microorganisms
Marine Derived Drugs Market, By Application:
- Anti-Cardiovascular
- Anti-Inflammatory
- Anti-Microbial
- Anti-Tumor
- Anti-Viral
Marine Derived Drugs Market, By Region:
- North America
- United States
- Canada
- Mexico
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- South America
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait
For more information about this report visit https://www.researchandmarkets.com/r/vqsuuh
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
- Marine Derived Drugs Market
